Apple (NSDQ:AAPL) is upping its diagnostic game with the Apple Watch yet again, adding the ability to more accurately detect tremors for individuals with Parkinson’s Disease, according to a CNBC report.
The company is updating the bio-sensor laden smartwatch to make it easier for researchers to differentiate between random movement and the shakes and dyskinesia experienced by Parkinson’s patients while they’re under treatment from medication, according to the report.
The announcement came last week at Apple’s WWDC developer conference, CNBC reports.
The updated movement disorder API will allow developers to improve applications which track of the progression of Parkinson’s, according to the report, and is expected to positively impact research already underway exploring the use of wearables to track the disease’s progression.
The improvement could be a step in changing how Parkinson’s patients are treated, Parkinson’s researcher Peter Schmidt of East Carolina University’s Brody School of Medicine told CNBC.
Schmidt said that the watch could allow patients to identify exactly when their medications wear off throughout the day, as patients often take them at each meal and can experience long gaps between that can make symptoms more pronounced, according to the report.
“Many patients don’t know it’s happening and they think they’re getting tired or hungry and symptoms are returning. The small change could help make a big difference with their symptoms,” Schmidt told CNBC.
Earlier this month, Apple opened up its Health Records application to developers, allowing digital health companies to use electronic health record data to power applications on Apple’s iOS devices.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.